Compare GHRS & TRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GHRS | TRS |
|---|---|---|
| Founded | 2018 | 1986 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2021 | 2004 |
| Metric | GHRS | TRS |
|---|---|---|
| Price | $28.96 | $40.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | $41.38 | ★ $41.50 |
| AVG Volume (30 Days) | 233.7K | ★ 462.7K |
| Earning Date | 05-01-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.44% |
| EPS Growth | N/A | ★ 400.00 |
| EPS | N/A | ★ 21.40 |
| Revenue | N/A | ★ $645,720,000.00 |
| Revenue This Year | N/A | $5.42 |
| Revenue Next Year | N/A | $4.27 |
| P/E Ratio | ★ N/A | $1.91 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.32 | $29.93 |
| 52 Week High | $31.00 | $45.43 |
| Indicator | GHRS | TRS |
|---|---|---|
| Relative Strength Index (RSI) | 65.84 | 44.26 |
| Support Level | $12.88 | $39.24 |
| Resistance Level | $28.96 | $41.84 |
| Average True Range (ATR) | 1.66 | 1.34 |
| MACD | 0.10 | -0.32 |
| Stochastic Oscillator | 65.92 | 16.91 |
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
TriMas Corp designs, develops and manufactures a diverse set of products for the consumer products, and industrial markets . The company operates through two segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners. The packaging segment generates majority of its revenue.